Since 1999 International Alliances Limited (IAL), headed by P Reed Maurer, has conducted an annual survey to determine the most admired pharma companies in Japan. Each year, IAL evaluates 30 companies, 15 Japanese and 15 foreign affiliated firms. In 2011 it included the firms listed below:
Japanese
Ajinomoto, Astellas, Daiichi Sankyo, Dainippon Sumitomo, Eisai, Kyowa Hakko Kirin, Meiji Seika, Mitsubishi Tanabe, Nippon Shinyaku, Ono, Otsuka, Shionogi, Takeda, Teijin,Torii
Foreign
Abbott, AstraZeneca, Bayer, Bristol-Myers, Chugai (Roche group), Eli Lilly, GlaxoSmithKline, Janssen (J&J group), MSD (Merck & Co), Boehringer Ingelheim, Novartis, Novo Nordisk, Pfizer, sanofi-aventis, UCB
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze